Increased GABAergic Output in the Ventromedial Hypothalamus Contributes to Impaired Hypoglycemic Counterregulation in Diabetic Rats
Authors:
Open Access
- 23 April 2011
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 60 (5) , 1582-1589
Abstract
OBJECTIVE Impaired glucose counterregulation during hypoglycemia is well documented in patients with type 1 diabetes; however, the molecular mechanisms underlying this defect remain uncertain. We reported that the inhibitory neurotransmitter γ-aminobutyric acid (GABA), in a crucial glucose-sensing region within the brain, the ventromedial hypothalamus (VMH), plays an important role in modulating the magnitude of the glucagon and epinephrine responses to hypoglycemia and investigated whether VMH GABAergic tone is altered in diabetes and therefore might contribute to defective counterregulatory responses. RESEARCH DESIGN AND METHODS We used immunoblots to measure GAD65 protein (a rate-limiting enzyme in GABA synthesis) and microdialysis to measure extracellular GABA levels in the VMH of two diabetic rat models, the diabetic BB rat and the streptozotocin (STZ)-induced diabetic rat, and compared them with nondiabetic controls. RESULTS Both diabetic rat models exhibited an ~50% increase in GAD65 protein as well as a twofold increase in VMH GABA levels compared with controls under baseline conditions. Moreover, during hypoglycemia, VMH GABA levels did not change in the diabetic animals, whereas they significantly declined in nondiabetic animals. As expected, glucagon responses were absent and epinephrine responses were attenuated in diabetic rats compared with their nondiabetic control counterparts. The defective counterregulatory response in STZ-diabetic animals was restored to normal with either local blockade of GABAA receptors or knockdown of GAD65 in the VMH. CONCLUSIONS These data suggest that increased VMH GABAergic inhibition is an important contributor to the absent glucagon response to hypoglycemia and the development of counterregulatory failure in type 1 diabetes.Keywords
This publication has 44 references indexed in Scilit:
- Astrocytes are GABAergic cells that modulate microglial activityGlia, 2010
- Insulin Reciprocally Regulates Glucagon Secretion in HumansDiabetes, 2010
- Glucose prevents the fall in ventromedial hypothalamic GABA that is required for full activation of glucose counterregulatory responses during hypoglycemiaAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Influence of Insulin in the Ventromedial Hypothalamus on Pancreatic Glucagon Secretion In VivoDiabetes, 2010
- Effects of Antecedent GABAA Activation With Alprazolam on Counterregulatory Responses to Hypoglycemia in Healthy HumansDiabetes, 2010
- Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetesAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- Insulin Signaling in α Cells Modulates Glucagon Secretion In VivoCell Metabolism, 2009
- The Barrier of Hypoglycemia in DiabetesDiabetes, 2008
- GABA, a forgotten gliotransmitterProgress in Neurobiology, 2008
- Hierarchy of Physiological Responses to Hypoglycemia: Relevance to Clinical Hypoglycemia in Type I (Insulin Dependent) Diabetes Mellitus*Hormone and Metabolic Research, 1997